RecruitingPhase 2NCT04066296
Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine
A Double Blinded Randomized Control Trial in Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine
Sponsor
University of Colorado, Denver
Enrollment
100 participants
Start Date
Sep 8, 2019
Study Type
INTERVENTIONAL
Conditions
Summary
Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day readmissions
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Male or Female
- Adult (≥18 yo)
- Lumbar stenosis
Exclusion Criteria9
- Co-morbidities precluding surgery
- ≤18 yo
- Pregnant
- Breastfeeding
- Need for instrumented fusion
- Prisoners
- Intra-operative CSF leak (identified by gush of CSF)
- Daily pre-operative opioid use of > 25 morphine Eq/day
- Previous lumbar surgery at indicated level
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGLiposomal bupivacaine
Injection of either liposomal bupivicaine or standard local anesthetic during surgical procedure.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04066296
Related Trials
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
NCT030729272218 locations
Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery
NCT074890011 location
Study Comparing Local/ MAC Anesthesia in Lumbar Decompression
NCT049925722 locations
Presence of Dural Pulsation in Patients Diagnosed With Lumbar Spinal Stenosis
NCT072337981 location
Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery
NCT050297261 location